Infectious Vaccines Market Report

Global Infectious Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 08, 2022
  • PAGES：207
  • REPORT CODE：GMM800253
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.

    Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.

    Infectious Vaccines market report explains the definition, types, applications, major countries, and major players of the Infectious Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi Pasteur (France)

    • GlaxoSmithKline plc (UK)

    • Emergent Bio Solutions Inc (US)

    • MedImmune LLC (US)

    • CSL Limited (Australia)

    • Merck and Company (US)

    • Pfizer Inc (US)

    • Bavarian Nordic (Denmark)

    • Novartis AG (Switzerland)

    • Johnson and Johnson (US)

    By Type:

    • Preventive vaccine

    • Therapeutic vaccine

    By End-User:

    • Adults

    • Pediatrics

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Infectious Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Infectious Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Infectious Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Infectious Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Infectious Vaccines Market- Recent Developments

    • 6.1 Infectious Vaccines Market News and Developments

    • 6.2 Infectious Vaccines Market Deals Landscape

    7 Infectious Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Infectious Vaccines Key Raw Materials

    • 7.2 Infectious Vaccines Price Trend of Key Raw Materials

    • 7.3 Infectious Vaccines Key Suppliers of Raw Materials

    • 7.4 Infectious Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Infectious Vaccines Cost Structure Analysis

      • 7.5.1 Infectious Vaccines Raw Materials Analysis

      • 7.5.2 Infectious Vaccines Labor Cost Analysis

      • 7.5.3 Infectious Vaccines Manufacturing Expenses Analysis

    8 Global Infectious Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Infectious Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Infectious Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Infectious Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Infectious Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Preventive vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Infectious Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adults Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pediatrics Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Infectious Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Infectious Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Infectious Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Infectious Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Infectious Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Infectious Vaccines Consumption (2017-2022)

      • 10.3.2 UK Infectious Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Infectious Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Infectious Vaccines Consumption (2017-2022)

      • 10.3.5 France Infectious Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Infectious Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Infectious Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Infectious Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Infectious Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Infectious Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Infectious Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Infectious Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Infectious Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Infectious Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Infectious Vaccines Consumption (2017-2022)

      • 10.4.3 India Infectious Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Infectious Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Infectious Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Infectious Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Infectious Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Infectious Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Infectious Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Infectious Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Infectious Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Infectious Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Infectious Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Infectious Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Infectious Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Infectious Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Infectious Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Infectious Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Infectious Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Infectious Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Infectious Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Infectious Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Infectious Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Infectious Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Infectious Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Infectious Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Infectious Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Infectious Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Infectious Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Infectious Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Infectious Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Infectious Vaccines Consumption (2017-2022)

    11 Global Infectious Vaccines Competitive Analysis

    • 11.1 Sanofi Pasteur (France)

      • 11.1.1 Sanofi Pasteur (France) Company Details

      • 11.1.2 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi Pasteur (France) Infectious Vaccines Main Business and Markets Served

      • 11.1.4 Sanofi Pasteur (France) Infectious Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GlaxoSmithKline plc (UK)

      • 11.2.1 GlaxoSmithKline plc (UK) Company Details

      • 11.2.2 GlaxoSmithKline plc (UK) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GlaxoSmithKline plc (UK) Infectious Vaccines Main Business and Markets Served

      • 11.2.4 GlaxoSmithKline plc (UK) Infectious Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Emergent Bio Solutions Inc (US)

      • 11.3.1 Emergent Bio Solutions Inc (US) Company Details

      • 11.3.2 Emergent Bio Solutions Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Emergent Bio Solutions Inc (US) Infectious Vaccines Main Business and Markets Served

      • 11.3.4 Emergent Bio Solutions Inc (US) Infectious Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 MedImmune LLC (US)

      • 11.4.1 MedImmune LLC (US) Company Details

      • 11.4.2 MedImmune LLC (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 MedImmune LLC (US) Infectious Vaccines Main Business and Markets Served

      • 11.4.4 MedImmune LLC (US) Infectious Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 CSL Limited (Australia)

      • 11.5.1 CSL Limited (Australia) Company Details

      • 11.5.2 CSL Limited (Australia) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 CSL Limited (Australia) Infectious Vaccines Main Business and Markets Served

      • 11.5.4 CSL Limited (Australia) Infectious Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Merck and Company (US)

      • 11.6.1 Merck and Company (US) Company Details

      • 11.6.2 Merck and Company (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Merck and Company (US) Infectious Vaccines Main Business and Markets Served

      • 11.6.4 Merck and Company (US) Infectious Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Pfizer Inc (US)

      • 11.7.1 Pfizer Inc (US) Company Details

      • 11.7.2 Pfizer Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Pfizer Inc (US) Infectious Vaccines Main Business and Markets Served

      • 11.7.4 Pfizer Inc (US) Infectious Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Bavarian Nordic (Denmark)

      • 11.8.1 Bavarian Nordic (Denmark) Company Details

      • 11.8.2 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Bavarian Nordic (Denmark) Infectious Vaccines Main Business and Markets Served

      • 11.8.4 Bavarian Nordic (Denmark) Infectious Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Novartis AG (Switzerland)

      • 11.9.1 Novartis AG (Switzerland) Company Details

      • 11.9.2 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Novartis AG (Switzerland) Infectious Vaccines Main Business and Markets Served

      • 11.9.4 Novartis AG (Switzerland) Infectious Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Johnson and Johnson (US)

      • 11.10.1 Johnson and Johnson (US) Company Details

      • 11.10.2 Johnson and Johnson (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Johnson and Johnson (US) Infectious Vaccines Main Business and Markets Served

      • 11.10.4 Johnson and Johnson (US) Infectious Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Infectious Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Infectious Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Preventive vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Therapeutic vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Infectious Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Infectious Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Infectious Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Infectious Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Infectious Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Infectious Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Infectious Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Infectious Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Infectious Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Infectious Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Infectious Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Infectious Vaccines

    • Figure of Infectious Vaccines Picture

    • Table Global Infectious Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Infectious Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Preventive vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatrics Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Vaccines Consumption by Country (2017-2022)

    • Table North America Infectious Vaccines Consumption by Country (2017-2022)

    • Figure United States Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Infectious Vaccines Consumption by Country (2017-2022)

    • Figure Germany Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Infectious Vaccines Consumption by Country (2017-2022)

    • Figure China Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Infectious Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Infectious Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Infectious Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Infectious Vaccines Consumption by Country (2017-2022)

    • Figure Australia Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table Sanofi Pasteur (France) Company Details

    • Table Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur (France) Infectious Vaccines Main Business and Markets Served

    • Table Sanofi Pasteur (France) Infectious Vaccines Product Portfolio

    • Table GlaxoSmithKline plc (UK) Company Details

    • Table GlaxoSmithKline plc (UK) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (UK) Infectious Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline plc (UK) Infectious Vaccines Product Portfolio

    • Table Emergent Bio Solutions Inc (US) Company Details

    • Table Emergent Bio Solutions Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent Bio Solutions Inc (US) Infectious Vaccines Main Business and Markets Served

    • Table Emergent Bio Solutions Inc (US) Infectious Vaccines Product Portfolio

    • Table MedImmune LLC (US) Company Details

    • Table MedImmune LLC (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune LLC (US) Infectious Vaccines Main Business and Markets Served

    • Table MedImmune LLC (US) Infectious Vaccines Product Portfolio

    • Table CSL Limited (Australia) Company Details

    • Table CSL Limited (Australia) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited (Australia) Infectious Vaccines Main Business and Markets Served

    • Table CSL Limited (Australia) Infectious Vaccines Product Portfolio

    • Table Merck and Company (US) Company Details

    • Table Merck and Company (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck and Company (US) Infectious Vaccines Main Business and Markets Served

    • Table Merck and Company (US) Infectious Vaccines Product Portfolio

    • Table Pfizer Inc (US) Company Details

    • Table Pfizer Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc (US) Infectious Vaccines Main Business and Markets Served

    • Table Pfizer Inc (US) Infectious Vaccines Product Portfolio

    • Table Bavarian Nordic (Denmark) Company Details

    • Table Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic (Denmark) Infectious Vaccines Main Business and Markets Served

    • Table Bavarian Nordic (Denmark) Infectious Vaccines Product Portfolio

    • Table Novartis AG (Switzerland) Company Details

    • Table Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Switzerland) Infectious Vaccines Main Business and Markets Served

    • Table Novartis AG (Switzerland) Infectious Vaccines Product Portfolio

    • Table Johnson and Johnson (US) Company Details

    • Table Johnson and Johnson (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson (US) Infectious Vaccines Main Business and Markets Served

    • Table Johnson and Johnson (US) Infectious Vaccines Product Portfolio

    • Figure Global Preventive vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US